Patent Number: 8,580,821

Title: Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety

Abstract: The present invention relates to trans-derivatives of formula ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, and the dotted line are as defined herein and to pharmaceutically acceptable acid addition salts thereof. The compounds of formula I are good inhibitors of the serotonin transporter (SERT inhibitors) and simultaneously, they have good activity on the NK-1 receptor (dual effect). By virtue of their efficacy as SERT inhibitors, the compounds in the present invention are particularly useful for the treatment of CNS disorders and psychotic disorders, in particular in the treatment or prevention of depressive states and/or in the treatment of anxiety.

Inventors: Grundschober; Christophe (Rodersdorf, CH), Schnider; Patrick (Bottmingen, CH)

Assignee: Hoffmann-La Roche Inc.

International Classification: A61K 31/445 (20060101); C07D 211/18 (20060101)

Expiration Date: 2022-11-12 0:00:00